SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Experian plc (EXPGY) trades at a trailing P/E of 28.6, forward P/E of 20.4. Trailing earnings yield is 3.50%, forward earnings yield 4.91%. PEG 0.50 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (60/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.50).
- Forward P/E 20.4 (down from trailing 28.6) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.50 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 3.50% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 4.91% as earnings recover.
Overall SharesGrow Score: 67/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
60/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — EXPGY
Valuation Multiples
P/E (TTM)28.6
Forward P/E20.4
PEG Ratio0.50
Forward PEG0.50
P/B Ratio0.00
P/S Ratio4.41
EV/EBITDA0.0
Per Share Data
EPS (TTM)$1.26
Forward EPS (Est.)$1.77
Book Value / Share$0.00
Revenue / Share$8.16
FCF / Share$0.00
Yields & Fair Value
Earnings Yield3.50%
Forward Earnings Yield4.91%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.79 |
$4.55B |
$753M |
16.5% |
| 2017 |
$0.91 |
$4.34B |
$866M |
20% |
| 2018 |
$0.88 |
$4.66B |
$783M |
16.8% |
| 2019 |
$0.76 |
$4.86B |
$695M |
14.3% |
| 2020 |
$0.74 |
$5.18B |
$675M |
13% |
| 2021 |
$0.88 |
$5.37B |
$803M |
14.9% |
| 2022 |
$1.26 |
$6.29B |
$1.17B |
18.5% |
| 2023 |
$0.84 |
$6.62B |
$770M |
11.6% |
| 2024 |
$1.30 |
$7.1B |
$1.2B |
16.9% |
| 2025 |
$1.26 |
$7.52B |
$1.17B |
15.5% |
